CN1306857A - Medicine for strengthening physique and strengthening immunity - Google Patents
Medicine for strengthening physique and strengthening immunity Download PDFInfo
- Publication number
- CN1306857A CN1306857A CN99106690A CN99106690A CN1306857A CN 1306857 A CN1306857 A CN 1306857A CN 99106690 A CN99106690 A CN 99106690A CN 99106690 A CN99106690 A CN 99106690A CN 1306857 A CN1306857 A CN 1306857A
- Authority
- CN
- China
- Prior art keywords
- medicine
- strengthening
- cortex phellodendri
- human body
- improve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is directly to one kind of medicine prepared with the active material including Tangut dragonhead herb with root, Cortex Phellodendri, Indian azalea, licorice, conic gymnadenia tuber an integripetal rhodiola herb. It can regulate body's oxygen free radical metabolism, strengthen immunity of body's cell, improve body blood oxygen pressure, improve body oxygen supply, improve microcirculation, reduce viscosity of blood, produce certain preventing and treating effect to anoxia of heat, brain an lung and produce obvious treating effect on asthenia.
Description
The invention belongs to a kind of Tibetan medicine, the medicine of particularly a kind of building body, enhancing human body immunity function.
Tibetan medicine has a long history and good common people basis, and Tibetan medicine is because of its growing environment uniqueness, strong, the good drug efficacy and pollution-free of the efficacy of a drug, belongs to the pure natural plant medical material and is subjected to the favor of Tibetan people deeply.But for a certain reason, the development and use and the pharmacological research thereof of relevant Tibetan medicine also are in hysteretic state.Therefore, the medicine of how developing building body, enhancing human body immunity function and be used for the treatment of the heart, brain, ischemia of lung anoxia illness from Tibetan medicine is the target that the medical worker extremely yearns for.
China is multi-nationality country, and various nationalities' medicine is characteristics slightly.Adopt fully natural green Tibetan medicine medical material building body at present, human body immunity improving power, and be used to prevent and treat the problem that some disease becomes people's concern.We studies show that, this medicine has building body, the human body immunity improving function, and be used for the physical weakness that some disease causes, weak unable, and have the effect for the treatment of the heart, brain, ischemia of lung anoxia illness concurrently.
The objective of the invention is to utilize Qinghai-Tibet pure natural Tibetan medicine, Chinese crude drug that a kind of building body is provided, the enhancing human body immunity function also is used for the treatment of the medicine of the heart, brain, ischemia of lung anoxia illness, it is used for the body weakness that some disease causes for the enhancing human body immunity function, the weak unable and heart, brain, ischemia of lung anoxia epidemic disease are suffered from, remarkable efficacy is arranged, this medicine good effect, have no side effect.
The present invention is achieved in that the Rhizoma Gymnadeniae of pure natural Qinghai-Tibet Platean local products, Herba Dracocephali tangutici, Rhododendron anthopogonoides Maxim., Cortex Phellodendri, Radix Rhodiolae, and Radix Glycyrrhizae is that raw material develops through science processing compatibility.It is characterized in that it is to make with the activated feedstock of the percentage by weight of following every consumption
Herba Dracocephali tangutici 0.1-99% Cortex Phellodendri 0.1-80%
Rhododendron anthopogonoides Maxim. 0.1-99% Radix Glycyrrhizae 0.1-99%
Rhizoma Gymnadeniae 0.1-99% Radix Rhodiolae 0.1-99%
Its best proportioning is:
Herba Dracocephali tangutici 5-50% Cortex Phellodendri 1-30%
Rhododendron anthopogonoides Maxim. 10-50% Radix Glycyrrhizae 2-50%
Rhizoma Gymnadeniae 5--50% Radix Rhodiolae 3-40%
Medicine provided by the invention can make the malonaldehyde (MDA) of body reflection oxygen-derived free radicals content obviously reduce, the ability of removing oxygen-derived free radicals strengthens, being that superoxide dismutase (SOD) and glutathion peroxidase (GSII-PX) are active raises, hematid immunity function strengthens, show that this medicine has adjusting and improvement effect to radical metabolism disorder in the human body, energy enhancing human body immunity function, improving the body blood system presses, have anti-hypoxia and improve sleep, physical strength reinforcing, the enhancing human body immunity function, and the heart, brain, ischemia of lung anoxia epidemic disease suffered from certain therapeutical effect.The effective in cure height of this medical instrument, the characteristics that have no side effect.
Manufacturing process of the present invention is a common process, promptly earlier with various medicines in proportion respectively infusion concentrate and make fluid extract, extract dry (being active ingredient) in the fluid extract, mix and add adjuvant then and can make various dosage forms such as oral liquid, capsule, tablet, powder
Below be several full implementation example of the present invention:
Embodiment 1
Herba Dracocephali tangutici 20% Cortex Phellodendri 15%
Rhododendron anthopogonoides Maxim. 20% Radix Glycyrrhizae 15%
Rhizoma Gymnadeniae 20% Radix Rhodiolae 10%
In the mixture of active ingredient, add syrup, make nourushing syrup with medicine-feeding
Embodiment 2
Herba Dracocephali tangutici 2% Cortex Phellodendri 20%
Rhododendron anthopogonoides Maxim. 50% Radix Glycyrrhizae 10%
Rhizoma Gymnadeniae 8% Radix Rhodiolae 10%
In the mixture of active ingredient, make tablet with soluble starch with medicine-feeding.
Embodiment 3
Herba Dracocephali tangutici 30% Cortex Phellodendri 40%
Rhododendron anthopogonoides Maxim. 5% Radix Glycyrrhizae 5%
Rhizoma Gymnadeniae 15% Radix Rhodiolae 5%
In the mixture of active ingredient, make capsule with soluble starch with medicine-feeding.
Embodiment 4
Herba Dracocephali tangutici 25% Cortex Phellodendri 10%
Rhododendron anthopogonoides Maxim. 10% Radix Glycyrrhizae 15%
Rhizoma Gymnadeniae 25% Radix Rhodiolae 15%
In the mixture of active ingredient, make powder with soluble starch with medicine-feeding.
Claims (2)
1, the medicine of a kind of building body, enhancing human body immunity function is characterized in that it is to make with the activated feedstock of the percentage by weight of following every consumption:
Rhizoma Gymnadeniae 0.1-99% Herba Dracocephali tangutici 0.1-99%
Rhododendron anthopogonoides Maxim. 0.1-99% Cortex Phellodendri 0.1-80%
Radix Rhodiolae 0.1-99% Radix Glycyrrhizae 0.1-99%
2, the medicine of a kind of building body according to claim 1, enhancing human body immunity function is characterized in that it can also be that the activated feedstock of the percentage by weight of following every consumption is made:
Herba Dracocephali tangutici 5-50% Cortex Phellodendri 1-30%
Rhododendron anthopogonoides Maxim. 10-50% Radix Glycyrrhizae 2-50%
Radix Rhodiolae 3-40% Rhizoma Gymnadeniae 5-50%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99106690A CN1104253C (en) | 1999-05-25 | 1999-05-25 | Medicine for strengthening physique and strengthening immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99106690A CN1104253C (en) | 1999-05-25 | 1999-05-25 | Medicine for strengthening physique and strengthening immunity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1306857A true CN1306857A (en) | 2001-08-08 |
| CN1104253C CN1104253C (en) | 2003-04-02 |
Family
ID=5272477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99106690A Expired - Fee Related CN1104253C (en) | 1999-05-25 | 1999-05-25 | Medicine for strengthening physique and strengthening immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1104253C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100413496C (en) * | 2002-12-31 | 2008-08-27 | 中国医学科学院药物研究所 | The use of sussinate derivative esters for the treatment of dementia |
| CN104920743A (en) * | 2015-07-20 | 2015-09-23 | 青海省通天河藏药制药有限责任公司 | Preparation method for anti-fatigue substitutional tea |
| CN105287723A (en) * | 2015-11-19 | 2016-02-03 | 西藏大学 | Nepeta hemsleyana compound essential oil and preparation method thereof |
-
1999
- 1999-05-25 CN CN99106690A patent/CN1104253C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100413496C (en) * | 2002-12-31 | 2008-08-27 | 中国医学科学院药物研究所 | The use of sussinate derivative esters for the treatment of dementia |
| CN101015648B (en) * | 2002-12-31 | 2010-05-26 | 中国医学科学院药物研究所 | Use of succinic acid derivative eater compound for treating dementia |
| CN104920743A (en) * | 2015-07-20 | 2015-09-23 | 青海省通天河藏药制药有限责任公司 | Preparation method for anti-fatigue substitutional tea |
| CN105287723A (en) * | 2015-11-19 | 2016-02-03 | 西藏大学 | Nepeta hemsleyana compound essential oil and preparation method thereof |
| CN105287723B (en) * | 2015-11-19 | 2019-08-09 | 西藏大学 | A kind of hiding schizonepeta compound essential oil and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1104253C (en) | 2003-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111097040A (en) | Antiviral lung-heat clearing peptide | |
| CN1709490A (en) | Health-care tea for reducing blood pressure and fat | |
| CN1104253C (en) | Medicine for strengthening physique and strengthening immunity | |
| CN1583001A (en) | Infrared cough relieving paste | |
| CN1530122A (en) | Chinese medicine for treating injury | |
| CN1196491C (en) | Ointment for healing tranumatic injury fast | |
| CN1255150C (en) | Chinese medicine preparation for curing hyperosteogeny and its preparation method | |
| CN1903352A (en) | Medicine for treating beriberi | |
| CN1194724C (en) | Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof | |
| CN1176690C (en) | Medicine for treating chronic nephritis | |
| CN1958054A (en) | Prescription of external wash liquid of duplicated solarized Chinese traditional medicine, and preparation method | |
| CN1583073A (en) | Chinese patent medicinal prescription for catch-cold | |
| CN1062769C (en) | Medicine for anti-anoxia and treating chronic hepatitis | |
| CN1618439A (en) | Broad-specturm medicine for treating snake venom poisoning | |
| CN1158093C (en) | Medicine composition containing yak bone for treating rhenmatism and method for making same | |
| CN1236809C (en) | Trauma treating medicament and method for making same | |
| CN1053115C (en) | Medicine for acute diarrhea of baby and preparation thereof | |
| CN1686322A (en) | Blood fat reducing granules containing seed of pepper weed or flixweed tansymustard | |
| CN1061252C (en) | Preparation of Chinese medicine for curing cardiac and cerebral diseases atomized by oxygen and its preparation process | |
| CN1270754C (en) | Gastropathy treating medicine and its preparation | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| CN1275633C (en) | Chinese traditional preparation for treating prostatitis | |
| CN1244421A (en) | Preparation of antiviral Guzaoke | |
| CN1168483C (en) | Heart disease treating medicine | |
| CN1065137C (en) | Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |